Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Macrogenics (MGNX) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Macrogenics (MGNX) over the last 14 years, with Q3 2025 value amounting to $16.8 million.

  • Macrogenics' Consolidated Net Income fell 7012.56% to $16.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$77.6 million, marking a year-over-year increase of 2512.45%. This contributed to the annual value of -$67.0 million for FY2024, which is 63930.23% down from last year.
  • As of Q3 2025, Macrogenics' Consolidated Net Income stood at $16.8 million, which was down 7012.56% from -$36.3 million recorded in Q2 2025.
  • In the past 5 years, Macrogenics' Consolidated Net Income registered a high of $56.3 million during Q3 2024, and its lowest value of -$66.6 million during Q1 2022.
  • Its 5-year average for Consolidated Net Income is -$32.9 million, with a median of -$41.8 million in 2022.
  • As far as peak fluctuations go, Macrogenics' Consolidated Net Income tumbled by 258368.66% in 2021, and later skyrocketed by 25860.8% in 2024.
  • Quarter analysis of 5 years shows Macrogenics' Consolidated Net Income stood at -$58.2 million in 2021, then soared by 120.58% to $12.0 million in 2022, then plummeted by 511.87% to -$49.4 million in 2023, then soared by 68.75% to -$15.4 million in 2024, then surged by 209.09% to $16.8 million in 2025.
  • Its last three reported values are $16.8 million in Q3 2025, -$36.3 million for Q2 2025, and -$42.7 million during Q1 2025.